Tag: <span>IL-6</span>


Delayed-Phase Thrombocytopenia in patients of COVID-19

Although the prevalence of thrombocytopenia (condition in which you have a low blood platelet count) at the time of admission of a patient with COVID-19 was already known, it has now also been demonstrated at a late stage. A new study at Union Hospital, in Wuhan, China, suggests that 11.8% of hospitalized patients suffer from...


Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients

The pandemic Coronavirus-disease 19 (COVID-19) is characterized by a heterogeneous clinical course. While most patients experience only mild symptoms, a relevant proportion develop severe disease progression with increasing hypoxia up to acute respiratory distress syndrome. The substantial number of patients with severe disease have strained intensive care capacities to an unprecedented level. In this way,...